VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Yahoo FinanceDec 12, 2024 21:00

VolitionRX Shares Are Trading Higher After the Company Announced a Study Showed Its Nu.Q Lung Cancer Test Achieved 92% Sensitivity and 89% Positive Predictive Value in Differentiating Malignant From Benign Pulmonary Nodules.

BenzingaDec 10, 2024 21:52

Express News | VolitionRX Announces Pricing of up to $1.9 Million Registered Direct Offering

BreakingsDec 6, 2024 22:00

VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering

PR NewswireDec 6, 2024 22:00

Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating

Futu NewsNov 22, 2024 20:33 · Ratings

VolitionRX (VNRX) Gets a Hold From Benchmark Co.

TipRanksNov 22, 2024 20:02 · Ratings